Your search returned 6 results.

Sort
Results
1.
Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold System. MedStar authors:
  • Rogers, Toby
  • Steinvil, Arie
  • Torguson, Rebecca
  • Waksman, Ron
PMID:
  • 27609249
Year: 2016
Citation:
  • Jacc: Cardiovascular Interventions. 9(17):1757-64, 2016 Sep 12
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Rogers T, Steinvil A, Torguson R, Waksman R
2.
Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial). MedStar authors:
  • Swymelar, Stacy
  • Torguson, Rebecca
  • Waksman, Ron
PMID:
  • 22762711
Year: 2012
Citation:
  • American Journal of Cardiology. 110(8):1119-24, 2012 Oct 15.
Institution:
  • MedStar Health Research Institute
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Dobies D, Ghali M, Goodroe R, Kaneshige K, McGarry T, Ring M, Ryan T, Shammas N, Steinberg DH, Swymelar S, Torguson R, Turco M, Waksman R
3.
Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach. MedStar authors:
  • Waksman, Ron
PMID:
  • 29129253
Year: 2017
Citation:
  • American Heart Journal. 193:35-45, 2017 Nov
Institution:
  • MedStar Heart & Vascular Instituteon
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Cutlip DE, Doros G, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Waksman R
4.
Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial. MedStar authors:
  • Garcia-Garcia, Hector M
  • Waksman, Ron
PMID:
  • 32499026
Year: 2020
Citation:
  • Jacc: Cardiovascular Interventions. 13(11):1343-1353, 2020 06 08.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
5.
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients. MedStar authors:
  • Garcia-Garcia, Hector M
  • Waksman, Ron
PMID:
  • 30354631
Year: 2018
Citation:
  • Circulation: Cardiovascular Interventions. 11(10):e007331, 2018 Oct.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bennett J, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Marcusohn E, Massaro JM, Roguin A, Waksman R
6.
Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial. MedStar authors:
  • Garcia-Garcia, Hector M
  • Waksman, Ron
PMID:
  • 32268942
Year: 2020
Citation:
  • Clinical Therapeutics. 42(4):649-660.e9, 2020 04.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • BIOFLOW VI Trial Investigators, Gao R, Garcia-Garcia HM, Guan C, Han Y, Li C, Song D, Waksman R, Xu B, Xu J, Yang Y
Pages

Powered by Koha